Logo

Promising drug combinations for immunotherapy-resistant melanoma may also help reactivate immune system

Promising drug combinations for immunotherapy-resistant melanoma may also help reactivate immune system

Researchers at Sutter's California Pacific Medical Center (CPMC) in San Francisco, Calif. have identified potential new therapeutic strategies for patients with advanced melanoma who no longer respond to immunotherapy—an aim representing one of the most pressing clinical challenges in cancer care today.

👉 Full Story